Skip to main content
AMCP Nexus 2023 Main banner

Jonathan D. Campbell, PhD

Chief Science Officer
National Pharmaceutical Council
Washington, DC

Jonathan D. (Jon) Campbell, MS, PhD, is the Chief Science Officer (CSO) of the National Pharmaceutical Council (NPC).
As CSO, Dr. Campbell leads NPC’s research agenda in concert with NPC’s board and research team. Dr. Campbell is dedicated to conducting research that helps decision-makers understand the tradeoffs and consequences of health policies that impact patient access to treatments and the ecosystem of biopharmaceutical innovation.
.
Dr. Campbell shaped his career within academics. After training at the University of Washington, he joined the faculty at the University of Colorado Anschutz Medical Campus, earning multiple appointments in Pharmacy and Public Health from 2009 to 2020. Prior to joining NPC, Dr. Campbell served as Senior Vice President for Health Economics at the Institute for Clinical and Economic Review (ICER), where he made contributions to ICER assessments and their value assessment methodology. Dr. Campbell is an author of over 250 manuscripts and abstracts in the field of health policy research and value assessment and holds an adjunct faculty appointment within the Center for Evaluation of Value and Risk in Health at Tufts University School of Medicine. Dr. Campbell’s training includes graduate degrees in pharmaceutical outcomes research (PhD) and biostatistics (MS) from the University of Washington. He graduated Phi Beta Kappa with Bachelor of Arts degrees in mathematics and chemistry from St. Olaf College.

Disclosure information not submitted.

Presentation(s):